PILLvsNVDLETF Comparison
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) and GraniteShares 2x Long NVDA Daily ETF (NVDL) belong to the same industry segment: Leveraged Equity. PILL is more expensive with a Total Expense Ratio (TER) of 1.22%, versus 1.06% for NVDL. PILL is up 14.62% year-to-date (YTD) with -$4M in YTD flows. NVDL performs worse with 6.68% YTD performance, and -$1.74B in YTD flows. Run a side-by-side ETF comparison of PILL and NVDL below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PILL vs NVDL performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PILL NVDL | -18.37%-15.41% | -27.18%-5.55% | +14.62%+6.68% | +65.29%+8.78% | +178.59%+659.84% | -18.57%n/a |
| Flows | PILL NVDL | -$774K+$4M | -$774K-$439M | -$4M-$1.74B | -$3M-$1.53B | -$7M-$1.17B | -$17M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PILL NVDL | +67.77%+74.89% | +69.76%+75.00% | +62.47%+92.45% | +63.79%n/a |
| Max drawdown | PILL NVDL | -44.35%-22.16% | -44.35%-42.21% | -60.51%-67.57% | -82.09%n/a |
| Max drawdown duration | PILL NVDL | 68d16d | 68d194d | 375d401d | 1743dn/a |
PILL | NVDL | |
Last sale 10/26/2026 at 1:30 PM | $14.01 | $32.37 |
| Previous close 10/26/2026 | $13.90 | $30.91 |
| Consolidated volume 10/26/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PILL | NVDL | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PILL | NVDL | |
|---|---|---|
| Last price | $14.01 | $32.37 |
| 1D performance | +0.79% | +4.72% |
| AuM | $14.73 M | $3.20 B |
| E/R | 1.22% | 1.06% |
PILL | NVDL | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Direxion | GraniteShares |
| Benchmark | S&P Pharmaceuticals Select Industry Index | NVIDIA |
| N° of holdings | - | - |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 15, 2017 | December 13, 2022 |
| ESG | No | No |
Exposure data will be available soon
